Aldosterone in Chronic Kidney and Cardiac Disease

This publication has 35 references indexed in Scilit:

• HIV-associated nephropathy in African Americans11The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The publisher or recipient acknowledges right of the U.S. Government to retain a nonexclusive, royalty-free license in and to any copyright covering the article.
  Kidney International, 2003
• Nongenomic actions of steroid hormones
  Nature Reviews Molecular Cell Biology, 2003
• Spironolactone Abolishes the Relationship between Aldosterone and Plasminogen Activator Inhibitor-1 in Humans
  Journal of Clinical Endocrinology & Metabolism, 2002
• Aldosterone: A Mediator of Myocardial Necrosis and Renal Arteriopathy
  Endocrinology, 2000
• Cardiac aldosterone production and ventricular remodeling
  Kidney International, 2000
• Physiologic resistance to the action of aldosterone
  Kidney International, 2000
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
  New England Journal of Medicine, 1999
• Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
  The Lancet, 1999
• High glucose stimulates aldosterone-induced hypertrophy via type I mineralocorticoid receptors in neonatal rat cardiomyocytes
  Endocrinology, 1996
• Role of aldosterone in the remnant kidney model in the rat.
  Journal of Clinical Investigation, 1996